All participants | |||||
 | SC (n = 412)§ | TAU (n = 397) | ICBT (n = 415) | SCP (n = 183) | All (n = 1407) |
Age (s.d.) | 46.9 (17.1) | 45.5 (16.3) | 46.6 (16.8) | 52.3 (17.6) | 47.1 (17.0) |
Female (%) | 75% | 78% | 70% | 61% | 73% |
PHQ-9 (s.d.), baseline | 4.55 (4.95) | 4.98 (5.19) | 4.2 (4.61) | 4.86 (5.54) | 4.61 (5.01) |
PHQ-9 (s.d.), 12-week | 3.85 (2.94) | 4.12 (3.09) | 3.65 (2.74) | 4.04 (3.29) | 3.89 (2.98) |
within group difference (95% CI)* | 0.69 (0.50 to 0.98) | 0.88 (0.67 to 1.08) | 0.55 (0.37 to 0.73) | 0.82 (0.49 to 1.15) | 0.72 (0.61 to 0.82) |
EQ-5D-5 L (s.d.), baseline | 0.86 (0.11) | 0.84 (0.14) | 0.86 (0.12) | 0.86 (0.13) | 0.86 (0.12) |
EQ-5D-5 L (s.d.), 12-week | 0.88 (0.06) | 0.87 (0.08) | 0.88 (0.07) | 0.88 (0.08) | 0.88 (0.07) |
within group difference (95% CI)** | 0.022 (0.017 to 0.026) | 0.03 (0.024 to 0.035) | 0.022 (0.017 to 0.027) | 0.022 (0.014 to 0.03) | 0.024 (0.021 to 0.027) |
Depressed participants (PHQ-9 > 10 at baseline) | |||||
 | SC (n = 56) | TAU (n = 66) | ICBT (n = 50) | SCP (n = 34) | All (n = 206) |
Age (s.d.) | 44.7 (16.3) | 44.8 (14.2) | 42.2 (13.8) | 49.0 (16.4) | 44.8 (15.1) |
Female (%) | 80% | 70% | 70% | 74% | 74% |
PHQ-9 (s.d.), baseline | 14.73 (4.17) | 14.83 (3.91) | 14.28 (3.76) | 14.85 (3.84) | 14.67 (3.91) |
PHQ-9 (s.d.), 12-week | 9.9 (2.48) | 9.94 (2.31) | 9.64 (2.24) | 9.98 (2.28) | 9.86 (2.32) |
within group difference (95% CI)* | 4.83 (4.37 to 5.28) | 4.85 (4.46 to 5.24) | 4.64 (4.21 to 5.08) | 4.88 (4.33 to 5.42) | 4.8 (4.58 to 5.02) |
EQ-5D-5 L (s.d.), baseline | 0.68 (0.18) | 0.63 (0.2) | 0.67 (0.22) | 0.68 (0.21) | 0.66 (0.2) |
EQ-5D-5 L (s.d.), 12-week | 0.78 (0.1) | 0.74 (0.12) | 0.77 (0.13) | 0.78 (0.12) | 0.76 (0.12) |
within group difference (95% CI)** | 0.095 (0.075 to 0.115) | 0.118 (0.096 to 0.139) | 0.1 (0.075 to 0.126) | 0.094 (0.064 to 0.125) | 0.103 (0.092 to 0.115) |